WO2024126876A2 - Antimicrobial compounds for oral care - Google Patents
Antimicrobial compounds for oral care Download PDFInfo
- Publication number
- WO2024126876A2 WO2024126876A2 PCT/EP2024/058509 EP2024058509W WO2024126876A2 WO 2024126876 A2 WO2024126876 A2 WO 2024126876A2 EP 2024058509 W EP2024058509 W EP 2024058509W WO 2024126876 A2 WO2024126876 A2 WO 2024126876A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- isosorbide
- causing microorganisms
- sorbitan
- oral care
- gingivitis
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 73
- 230000000845 anti-microbial effect Effects 0.000 title description 2
- 239000000203 mixture Substances 0.000 claims abstract description 127
- 244000005700 microbiome Species 0.000 claims abstract description 96
- 208000002064 Dental Plaque Diseases 0.000 claims abstract description 51
- 208000002925 dental caries Diseases 0.000 claims abstract description 51
- 208000007565 gingivitis Diseases 0.000 claims abstract description 50
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 44
- KLDXJTOLSGUMSJ-JGWLITMVSA-N Isosorbide Chemical class O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 KLDXJTOLSGUMSJ-JGWLITMVSA-N 0.000 claims abstract description 39
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims abstract description 33
- 229930195734 saturated hydrocarbon Natural products 0.000 claims abstract description 23
- 229930195735 unsaturated hydrocarbon Chemical group 0.000 claims abstract description 23
- 239000004599 antimicrobial Substances 0.000 claims abstract description 20
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical class OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 150000002430 hydrocarbons Chemical group 0.000 claims abstract 10
- 238000009472 formulation Methods 0.000 claims description 61
- -1 oral gel Substances 0.000 claims description 28
- 229960002479 isosorbide Drugs 0.000 claims description 21
- 239000000606 toothpaste Substances 0.000 claims description 21
- 229940034610 toothpaste Drugs 0.000 claims description 19
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 17
- 239000000194 fatty acid Substances 0.000 claims description 17
- 229930195729 fatty acid Natural products 0.000 claims description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- 150000004665 fatty acids Chemical class 0.000 claims description 13
- 230000001603 reducing effect Effects 0.000 claims description 13
- 150000005690 diesters Chemical class 0.000 claims description 12
- 230000000694 effects Effects 0.000 claims description 11
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 10
- 230000002265 prevention Effects 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 235000011187 glycerol Nutrition 0.000 claims description 7
- 239000002324 mouth wash Substances 0.000 claims description 7
- 229940051866 mouthwash Drugs 0.000 claims description 7
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims description 5
- 229960002446 octanoic acid Drugs 0.000 claims description 5
- NENOAJSZZPODGJ-OIMNJJJWSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] octanoate Chemical compound CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NENOAJSZZPODGJ-OIMNJJJWSA-N 0.000 claims description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 claims description 4
- 150000002191 fatty alcohols Chemical class 0.000 claims description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 claims description 4
- 229940105132 myristate Drugs 0.000 claims description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 claims description 4
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 claims description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims description 2
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 claims description 2
- CEZONBVMFRWNCJ-CYGHRXIMSA-N [(3r,3ar,6s,6ar)-3-hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] dodecanoate Chemical compound O[C@@H]1CO[C@@H]2[C@@H](OC(=O)CCCCCCCCCCC)CO[C@@H]21 CEZONBVMFRWNCJ-CYGHRXIMSA-N 0.000 claims description 2
- JDRAOGVAQOVDEB-JXYJBCOESA-N [(6s)-3-hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] (e)-octadec-9-enoate Chemical compound OC1COC2[C@@H](OC(=O)CCCCCCC/C=C/CCCCCCCC)COC21 JDRAOGVAQOVDEB-JXYJBCOESA-N 0.000 claims description 2
- 229940112822 chewing gum Drugs 0.000 claims description 2
- 235000015218 chewing gum Nutrition 0.000 claims description 2
- 229940041672 oral gel Drugs 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 229950006451 sorbitan laurate Drugs 0.000 claims description 2
- 235000011067 sorbitan monolaureate Nutrition 0.000 claims description 2
- 229950004959 sorbitan oleate Drugs 0.000 claims description 2
- 229950011392 sorbitan stearate Drugs 0.000 claims description 2
- 150000005691 triesters Chemical class 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 description 52
- 241000194019 Streptococcus mutans Species 0.000 description 43
- 125000001183 hydrocarbyl group Chemical group 0.000 description 34
- 240000001046 Lactobacillus acidophilus Species 0.000 description 29
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 25
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 25
- 235000002639 sodium chloride Nutrition 0.000 description 17
- 150000003839 salts Chemical class 0.000 description 14
- 241000605986 Fusobacterium nucleatum Species 0.000 description 13
- 241000605862 Porphyromonas gingivalis Species 0.000 description 13
- 241000194026 Streptococcus gordonii Species 0.000 description 13
- 241000194023 Streptococcus sanguinis Species 0.000 description 13
- 241000193987 Streptococcus sobrinus Species 0.000 description 13
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical class C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 12
- 239000002253 acid Substances 0.000 description 11
- 239000004094 surface-active agent Substances 0.000 description 11
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 7
- 229940091249 fluoride supplement Drugs 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 239000008399 tap water Substances 0.000 description 5
- 235000020679 tap water Nutrition 0.000 description 5
- 229940031723 1,2-octanediol Drugs 0.000 description 4
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 4
- 244000060011 Cocos nucifera Species 0.000 description 4
- 235000013162 Cocos nucifera Nutrition 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000003945 anionic surfactant Substances 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- VUWCWMOCWKCZTA-UHFFFAOYSA-N 1,2-thiazol-4-one Chemical class O=C1CSN=C1 VUWCWMOCWKCZTA-UHFFFAOYSA-N 0.000 description 3
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 3
- RKWGIWYCVPQPMF-UHFFFAOYSA-N Chloropropamide Chemical group CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1 RKWGIWYCVPQPMF-UHFFFAOYSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920006318 anionic polymer Polymers 0.000 description 3
- 230000002272 anti-calculus Effects 0.000 description 3
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000004088 foaming agent Substances 0.000 description 3
- 229920000591 gum Polymers 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 3
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- OSFBJERFMQCEQY-UHFFFAOYSA-N propylidene Chemical compound [CH]CC OSFBJERFMQCEQY-UHFFFAOYSA-N 0.000 description 3
- OEGPRYNGFWGMMV-UHFFFAOYSA-N (3,4-dimethoxyphenyl)methanol Chemical compound COC1=CC=C(CO)C=C1OC OEGPRYNGFWGMMV-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 2
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 2
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 description 2
- DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000003082 abrasive agent Substances 0.000 description 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium;phosphate;dihydrate Chemical compound O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229940100524 ethylhexylglycerin Drugs 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000012009 microbiological test Methods 0.000 description 2
- FWPKDESKJMMUSR-UHFFFAOYSA-N n-hydroxyhexanamide Chemical compound CCCCCC(=O)NO FWPKDESKJMMUSR-UHFFFAOYSA-N 0.000 description 2
- ZVVSSOQAYNYNPP-UHFFFAOYSA-N olaflur Chemical compound F.F.CCCCCCCCCCCCCCCCCCN(CCO)CCCN(CCO)CCO ZVVSSOQAYNYNPP-UHFFFAOYSA-N 0.000 description 2
- 229960001245 olaflur Drugs 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- OIQJEQLSYJSNDS-UHFFFAOYSA-N piroctone Chemical compound CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O OIQJEQLSYJSNDS-UHFFFAOYSA-N 0.000 description 2
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 2
- 229940081510 piroctone olamine Drugs 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000011698 potassium fluoride Substances 0.000 description 2
- 235000003270 potassium fluoride Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 2
- 229960002799 stannous fluoride Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- OWEGWHBOCFMBLP-UHFFFAOYSA-N 1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one Chemical compound C1=CN=CN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 OWEGWHBOCFMBLP-UHFFFAOYSA-N 0.000 description 1
- SNUSZUYTMHKCPM-UHFFFAOYSA-N 1-hydroxypyridin-2-one Chemical compound ON1C=CC=CC1=O SNUSZUYTMHKCPM-UHFFFAOYSA-N 0.000 description 1
- DUMOWKMELCQQQM-UHFFFAOYSA-N 1-phenoxyethanol;prop-1-ene Chemical compound CC=C.CC(O)OC1=CC=CC=C1 DUMOWKMELCQQQM-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- IRPGOXJVTQTAAN-UHFFFAOYSA-N 2,2,3,3,3-pentafluoropropanal Chemical compound FC(F)(F)C(F)(F)C=O IRPGOXJVTQTAAN-UHFFFAOYSA-N 0.000 description 1
- RIWRBSMFKVOJMN-UHFFFAOYSA-N 2-methyl-1-phenylpropan-2-ol Chemical compound CC(C)(O)CC1=CC=CC=C1 RIWRBSMFKVOJMN-UHFFFAOYSA-N 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- SLBAEZGCKDEGLB-UHFFFAOYSA-N 3-benzyl-1,2-thiazol-4-one Chemical compound O=C1CSN=C1CC1=CC=CC=C1 SLBAEZGCKDEGLB-UHFFFAOYSA-N 0.000 description 1
- VWJZZXVHKZPGLL-UHFFFAOYSA-N 3-methyldecane-1,2,3-triol Chemical compound CCCCCCCC(C)(C(CO)O)O VWJZZXVHKZPGLL-UHFFFAOYSA-N 0.000 description 1
- GUPXYSSGJWIURR-UHFFFAOYSA-N 3-octoxypropane-1,2-diol Chemical compound CCCCCCCCOCC(O)CO GUPXYSSGJWIURR-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 description 1
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 description 1
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- OZKLKDKGPNBGPK-UHFFFAOYSA-N 9-Dodecenoic acid Natural products CCCC=CCCCCCCC(O)=O OZKLKDKGPNBGPK-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- FKLSONDBCYHMOQ-UHFFFAOYSA-N 9E-dodecenoic acid Natural products CCC=CCCCCCCCC(O)=O FKLSONDBCYHMOQ-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- KLZUFWVZNOTSEM-UHFFFAOYSA-K Aluminum fluoride Inorganic materials F[Al](F)F KLZUFWVZNOTSEM-UHFFFAOYSA-K 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229920002670 Fructan Polymers 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- GMINEWVLJLPVAX-XOSAIJSUSA-N N-methyl-N-[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]dec-9-enamide Chemical compound CN(C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO)C(CCCCCCCC=C)=O GMINEWVLJLPVAX-XOSAIJSUSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- DYUQAZSOFZSPHD-UHFFFAOYSA-N Phenylpropanol Chemical compound CCC(O)C1=CC=CC=C1 DYUQAZSOFZSPHD-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical group [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 235000015125 Sterculia urens Nutrition 0.000 description 1
- 240000001058 Sterculia urens Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 229960003168 bronopol Drugs 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 229910001634 calcium fluoride Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 1
- 229960005443 chloroxylenol Drugs 0.000 description 1
- 229960003993 chlorphenesin Drugs 0.000 description 1
- 229960003344 climbazole Drugs 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- LRCFXGAMWKDGLA-UHFFFAOYSA-N dioxosilane;hydrate Chemical compound O.O=[Si]=O LRCFXGAMWKDGLA-UHFFFAOYSA-N 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960004667 ethyl cellulose Drugs 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- GCXZDAKFJKCPGK-UHFFFAOYSA-N heptane-1,2-diol Chemical compound CCCCCC(O)CO GCXZDAKFJKCPGK-UHFFFAOYSA-N 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940040102 levulinic acid Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 229940100573 methylpropanediol Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- HINLVYCXMWGFEP-UHFFFAOYSA-N n-hydroxydodecanamide Chemical compound CCCCCCCCCCCC(=O)NO HINLVYCXMWGFEP-UHFFFAOYSA-N 0.000 description 1
- RAHASHNKFGYCHF-QFHJOOASSA-N n-methyl-n-[(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]dodec-9-enamide Chemical compound CCC=CCCCCCCCC(=O)N(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO RAHASHNKFGYCHF-QFHJOOASSA-N 0.000 description 1
- GBMPATKVZSIKPO-UYWIDEMCSA-N n-methyl-n-[(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]tetradecanamide Chemical compound CCCCCCCCCCCCCC(=O)N(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO GBMPATKVZSIKPO-UYWIDEMCSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229950009195 phenylpropanol Drugs 0.000 description 1
- 229950001046 piroctone Drugs 0.000 description 1
- 229920005646 polycarboxylate Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Chemical compound [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 description 1
- 229940099402 potassium metaphosphate Drugs 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940095574 propionic acid Drugs 0.000 description 1
- GGOZGYRTNQBSSA-UHFFFAOYSA-N pyridine-2,3-diol Chemical class OC1=CC=CN=C1O GGOZGYRTNQBSSA-UHFFFAOYSA-N 0.000 description 1
- YBBJKCMMCRQZMA-UHFFFAOYSA-N pyrithione Chemical compound ON1C=CC=CC1=S YBBJKCMMCRQZMA-UHFFFAOYSA-N 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 229960004029 silicic acid Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940065859 sodium cocoyl glycinate Drugs 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 229940045990 sodium laureth-2 sulfate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 1
- 229940075560 sodium lauryl sulfoacetate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 229940048109 sodium methyl cocoyl taurate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- GUQPDKHHVFLXHS-UHFFFAOYSA-M sodium;2-(2-dodecoxyethoxy)ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOS([O-])(=O)=O GUQPDKHHVFLXHS-UHFFFAOYSA-M 0.000 description 1
- IKGKWKGYFJBGQJ-UHFFFAOYSA-M sodium;2-(dodecanoylamino)acetate Chemical compound [Na+].CCCCCCCCCCCC(=O)NCC([O-])=O IKGKWKGYFJBGQJ-UHFFFAOYSA-M 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- HFQQZARZPUDIFP-UHFFFAOYSA-M sodium;2-dodecylbenzenesulfonate Chemical compound [Na+].CCCCCCCCCCCCC1=CC=CC=C1S([O-])(=O)=O HFQQZARZPUDIFP-UHFFFAOYSA-M 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- FKLSONDBCYHMOQ-ONEGZZNKSA-N trans-dodec-9-enoic acid Chemical compound CC\C=C\CCCCCCCC(O)=O FKLSONDBCYHMOQ-ONEGZZNKSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- VSJRDSLPNMGNFG-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate;trihydrate Chemical compound O.O.O.[Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O VSJRDSLPNMGNFG-UHFFFAOYSA-H 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 229940085658 zinc citrate trihydrate Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Definitions
- the present invention relates to the use of certain compounds as antimicrobial agents against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms, as well as to oral care formulations.
- the present invention also relates to certain compounds for use in reducing the effects of dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms, to certain compounds for use in the prevention or treatment of dental caries, dental plaque or gingivitis, to oral care formulations for use in reducing the effects of dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms, and to oral care formulations for use in the prevention or treatment of dental caries, dental plaque or gingivitis.
- Oral care is important for general hygiene and overall well-being.
- Oral care includes, among others, brushing the teeth with toothpaste and rinsing the mouth with mouthwash.
- S. mutans Streptococcus mutans
- S. mutans produces sticky, adhesive glucans and fructans from fermentable sugars, particularly sucrose, which promote the adhesion of bacteria to the oral surfaces.
- Dental plaque is a sticky biofilm or mass of bacteria that is commonly found on the teeth, along the gum line, and below the gum line margins. Dental plaque can give rise to dental caries and gingivitis.
- the present invention relates to the use of compound X selected from compounds of Formula (I) wherein R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof, glyceryl ethers, sorbitan esters, and isosorbide esters as an antimicrobial agent against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
- the compounds used in the present invention have a high renewable carbon content, i.e. they are sustainable.
- the compounds used in the present invention can be incorporated into an oral care formulation.
- compound X selected from compounds of Formula (I) wherein R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof, glyceryl ethers, sorbitan esters, and isosorbide esters is used as an antimicrobial agent against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
- compound X is selected from compounds of Formula (I) wherein R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof, glyceryl ethers, sorbitan esters, and isosorbide esters.
- compound X selected from compounds of Formula (I) wherein R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof is used as an antimicrobial agent against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
- compound X is selected from compounds of Formula (I) wherein R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof.
- R in Formula (I) is selected from saturated hydrocarbon chains having 5 to 17 carbon atoms, unsaturated hydrocarbon chains having 5 to 17 carbon atoms, and mixtures thereof.
- R in Formula (I) is selected from saturated hydrocarbon chains having 5 to 13 carbon atoms, unsaturated hydrocarbon chains having 5 to 13 carbon atoms, and mixtures thereof.
- R in Formula (I) is selected from saturated hydrocarbon chains having 7 to 9 carbon atoms, unsaturated hydrocarbon chains having 7 to 9 carbon atoms, and mixtures thereof.
- the weight ratio of compounds according to Formula (I) wherein R is - (CH2)eCH3 and compounds according to Formula (I) wherein R is -(CF ⁇ sCHs is from 1 :9 to 9:1 , preferably from 3:7 to 7:3.
- the weight ratio of compounds according to Formula (I) wherein R is - (CH 2 )IOCH 3 and compounds according to Formula (I) wherein R is -(CH2)i2CH3 is from 1 :9 to 9:1 , preferably from 3:7 to 7:3.
- the compound of Formula (I) is soluble in water. Therefore, the compound of Formula (I) is suitable for use in mouth wash formulations.
- compound X selected from glyceryl ethers is used as an antimicrobial agent against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
- compound X is selected from glyceryl ethers.
- the glyceryl ethers are mono- or diethers of glycerin and one or more C6-C20 fatty alcohols. More preferably, the glyceryl ethers are mono- or diethers of glycerin and one or more C8-C14 fatty alcohols. Particularly preferably, the glyceryl ethers are monoethers of glycerin and one or more C8 fatty alcohols.
- the glyceryl ethers are selected from ethylhexylglycerin, methylheptylglycerin, caprylyl glyceryl ether, and mixtures thereof.
- compound X selected from sorbitan esters and isosorbide esters is used as an antimicrobial agent against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
- compound X is selected from sorbitan esters and isosorbide esters.
- compound X selected from sorbitan esters is used as an antimicrobial agent against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
- compound X is selected from sorbitan esters.
- the sorbitan esters are mono-, di- or triesters of sorbitan and one or more C6-C20 fatty acids. More preferably, the sorbitan esters are mono- or diesters of sorbitan and one or more C8-C14 fatty acids. Particularly preferably, the sorbitan esters are mono- or diesters of sorbitan and caprylic acid.
- the sorbitan esters are selected from sorbitan caprylate, sorbitan stearate, sorbitan olivate, sorbitan oleate, sorbitan caprate, sorbitan laurate, sorbitan myristate, sorbitan caproate, and mixtures thereof. Particularly preferably, the sorbitan ester is sorbitan caprylate.
- compound X selected from isosorbide esters is used as an antimicrobial agent against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
- compound X is selected from isosorbide esters.
- the isosorbide esters are mono- or diesters of isosorbide and one or more C6-C20 fatty acids. More preferably, the isosorbide esters are mono- or diesters of isosorbide and one or more C8-C14 fatty acids. Particularly preferably, the isosorbide esters are mono- or diesters of isosorbide and caprylic acid.
- the isosorbide esters are selected from isosorbide caprylate, isosorbide stearate, isosorbide olivate, isosorbide oleate, isosorbide caprate, isosorbide laurate, isosorbide myristate, isosorbide caproate, and mixtures thereof.
- the isosorbide ester is isosorbide caprylate.
- compound X is suitable for use in toothpaste formulations.
- compound X as defined herein is used as an antimicrobial agent against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
- microorganisms are Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis.
- Preferred microorganisms are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L acidophilus).
- the dental caries causing microorganisms are dental caries causing bacteria.
- the dental plaque causing microorganisms are dental plaque causing bacteria.
- the gingivitis causing microorganisms are gingivitis causing bacteria.
- compound X as defined herein is used as an antibacterial agent against dental caries causing bacteria, dental plaque causing bacteria or gingivitis causing bacteria.
- examples of such bacteria are Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis.
- Preferred bacteria are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L acidophilus).
- Streptococcus mutans, Streptococcus sanguinis and Streptococcus sobrinus are film formers.
- Streptococcus gordonii is a film former and an acid former.
- Lactobacillus acidophilus is an acid former. It attacks the dental enamel. Fusobacterium nucleatum is a film former. Porphyromonas gingivalis is responsible for periodentosis.
- compound X as defined herein is used in combination with a further antimicrobial agent.
- the antimicrobial agent is selected from the group consisting of: aromatic alcohols, organic acids and salts thereof, hydroxamic acids and salts thereof, hydroxyacetophenone, compounds according to Formula (P), alkyl diols, halogenated compounds, isothiazolinones, and mixtures thereof; wherein Formula (P) is as follows:
- R1 is H, an unsubstituted or halogen-substituted, branched or unbranched C-i- C2o-alkyl radical, an unsubstituted or halogen-substituted Cs-Cs-cycloalkyl radical, an unsubstituted or halogen-substituted Ce-C -aryl radical or an unsubstituted or halogen-substituted, branched or unbranched C7-C20- aralkyl radical;
- R2’ is 0 or S
- R3’ is H or a Ci-C4-alkyl radical
- X + is a cation
- R3' is methyl
- the aromatic alcohols are selected from the group consisting of benzyl alcohol, phenoxyethanol, veratryl alcohol, propylene phenoxyethanol, phenethyl alcohol, phenylpropanol, vanillin, 2-methyl-1 -phenyl- 2-propanol, and mixtures thereof.
- the organic acids and salts thereof are selected from the group consisting of benzoic acid, sorbic acid, dehydroacetic acid, lactic acid, salicylic acid, p-anisic acid, undecylenic acid, glycolic acid, propionic acid, levulinic acid, and mixtures thereof.
- the hydroxamic acid is selected from hydroxamic acids of Formula (III) wherein R 1 is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof.
- R 1 in Formula (III) is selected from saturated hydrocarbon chains having 5 to 17 carbon atoms, unsaturated hydrocarbon chains having 5 to 17 carbon atoms, and mixtures thereof. More preferably, R 1 in Formula (III) is selected from saturated hydrocarbon chains having 5 to 13 carbon atoms, unsaturated hydrocarbon chains having 5 to 13 carbon atoms, and mixtures thereof. Particularly preferably, R 1 in Formula (III) is selected from saturated hydrocarbon chains having 7 carbon atoms, unsaturated hydrocarbon chains having 7 carbon atoms, and mixtures thereof.
- Preferred hydroxamic acids are selected from caprylhydroxamic acid, hexanohydroxamic acid, caprohydroxamic acid, laurohydroxamic acid, and mixtures thereof.
- a particularly preferred hydroxamic acid is caprylhydroxamic acid.
- Caprylhydroxamic acid may also be referred to as caprylohydroxamic acid or octanohydroxamic acid.
- Hydroxamic acids are described in, e.g., EP2224973.
- salts of hydroxamic acids are alkali metal salts of hydroxamic acids (e.g. sodium salts of hydroxamic acids or potassium salts of hydroxamic acids) or alkaline earth metal salts of hydroxamic acids (e.g. magnesium salts of hydroxamic acids or calcium salts of hydroxamic acids).
- the compound according to Formula (P) is selected from the group consisting of 2-hydroxypyridine-N-oxide, 2-pyridinethiol-1 -oxide and salts thereof, 1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2(1 H)-pyridone and salts thereof (preferably the monoethanolamine salt), and mixtures thereof.
- Formula (P) discloses and encompasses the tautomeric equivalents of these compounds, since an equilibrium always exists.
- the compound according to Formula (P) is piroctone olamine (Octopirox).
- the alkyl diols are selected from the group consisting of 1 ,2-pentanediol, 1 ,2-hexanediol, 1 ,6-hexanediol, 1 ,2-octanediol, 1 ,2- heptanediol, 1 ,2-decanediol, methylpropanediol, and mixtures thereof.
- the halogenated compounds are selected from the group consisting of chlorhexidine and salts thereof, triclosan, chlorphenesin, trichlorcarban, chloroxylenol, bronopol, climbazole, and mixtures thereof.
- the isothiazolinones are selected from the group consisting of methylisothiazolinone, methylchloroisothiazolinone, benzylisothiazolinone, and mixtures thereof.
- the antimicrobial agent is selected from the group consisting of aromatic alcohols, organic acids and salts thereof, hydroxamic acids and salts thereof, hydroxyacetophenone, hydroxypyridones, alkyl diols, halogenated compounds, isothiazolinones, and mixtures thereof.
- the antimicrobial agent is selected from the group consisting of phenoxyethanol, benzyl alcohol, phenethyl alcohol, benzoic acid and salts thereof, caprylhydroxamic acid, hydroxyacetophenone, piroctone olamine, and mixtures thereof.
- the antimicrobial agent is 1 ,2-octanediol, in particular bio-based 1 ,2-octanediol, for example bio-1 ,2-octanediol as disclosed in WO 2019/152569.
- Suitable antimicrobial agents are also listed in Annex V (updated on 28/2022) of the REGULATION (EC) No 1223/2009 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 30 November 2009 on cosmetic products.
- the weight ratio of compound X as defined herein to the further antimicrobial agent, if present, is from 20:1 to 1 :20, more preferably from 15:1 to 1 :15, even more preferably from 10:1 to 1 :10, particularly preferably from 5:1 to 1 :5, for example 1 :1.
- the present invention also relates to an oral care formulation comprising from 0.1 to 20 wt.-%, preferably from 0.2 to 10 wt.-%, more preferably from 0.3 to 5 wt.-%, even more preferably from 0.4 to 3 wt.-%, particularly preferably from 0.5 to 2 wt.-%, based on the total weight of the oral care formulation, of compound X as defined herein.
- the oral care formulation is selected from the group consisting of toothpaste, oral gel, mouth wash, tooth powder and chewing gum.
- the oral care formulation is selected from the group consisting of toothpaste and mouth wash.
- the oral care formulation is a toothpaste.
- the oral care formulation is a mouth wash.
- the oral care formulation comprises a solvent.
- the solvent is preferably selected from water, propylene glycol, isopropanol, and mixtures thereof.
- the oral care formulation comprises a humectant.
- the humectant is preferably selected from sorbitol, glycerol, xylitol, and mixtures thereof.
- the humectant may, for example, be present in an amount of from 10 to 70 wt.-%, preferably from 30 to 60 wt.-%, for example from 40 to 55 wt.-%, based on the total weight of the oral care formulation.
- the oral care formulation comprises an abrasive.
- the abrasive is preferably selected from silica abrasives, hydrated silica, hydrated alumina, calcium abrasives, tricalcium phosphate, hydroxyapatite, dicalcium phosphate dihydrate, calcium pyrophosphate, calcium carbonate, sodium metaphosphate, potassium metaphosphate, aluminum silicate, calcined alumina, bentonite, sodium bicarbonate, and mixtures thereof.
- the abrasive may, for example, be present in an amount of from 10 to 30 wt.-%, preferably from 15 to 25 wt.-%, based on the total weight of the oral care formulation.
- the oral care formulation comprises an anticalculus agent.
- the anticalculus agent is preferably selected from phosphates, polyphosphates, pyrophosphates, e.g. tetrasodium pyrophosphate, polyaminopropanesulfonic acid, hexametaphosphate salts, zinc citrate trihydrate, polypeptides, polyolefin sulfonates, polyolefin phosphates, diphosphonates, and mixtures thereof.
- the anticalculus agent may, for example, be present in an amount of from 0.01 to 20 wt.-%, preferably from 0.1 to 10 wt.-%, based on the total weight of the oral care formulation.
- the oral care formulation comprises a fluoride source.
- the fluoride source is preferably selected from stannous fluoride, sodium fluoride, potassium fluoride, sodium monofluorophosphate, sodium fluorosilicate, ammonium fluorosilicate, amine fluoride, ammonium fluoride, calcium fluoride, aluminum fluoride, fluorohydroxyapatite, and mixtures thereof.
- the fluoride source is preferably selected from stannous fluoride, sodium fluoride, potassium fluoride, sodium monofluorophosphate, sodium fluorosilicate, ammonium fluorosilicate, amine fluoride, ammonium fluoride, and mixtures thereof.
- the fluoride source may, for example, be present in an amount of from 0.01 to 10 wt.-%, preferably from 0.1 to 2 wt.-%, based on the total weight of the oral care formulation.
- the fluoride source may, for example, be present in an amount of from 0.01 to 1 wt.-%, preferably from 0.02 to 0.5 wt.-%, more preferably from 0.03 to 0.3 wt.-%, even more preferably from 0.04 to 0.2 wt.-%, particularly preferably from 0.05 to 0.15 wt.-%, based on the total weight of the oral care formulation.
- the fluoride source may, for example, be present in an amount of from 0.01 to 0.15 wt.-%, preferably from 0.02 to 0.15 wt.-%, more preferably from 0.03 to 0.15 wt.-%, even more preferably from 0.04 to 0.15 wt.-%, particularly preferably from 0.05 to 0.15 wt.-%, based on the total weight of the oral care formulation.
- the oral care formulation is a toothpaste
- the toothpaste comprises a fluoride source.
- the oral care formulation comprises a polymer.
- the polymer is preferably selected from polyethylene glycols, polysaccharides, for example cellulose derivatives, for example carboxymethyl cellulose, hydroxymethyl cellulose, ethyl cellulose, microcrystalline cellulose, or polysaccharide gums, for example xanthan gum, guar gum or carrageenan gum, or polyacrylates or polymers based on N-vinylpyrrolidone, and mixtures thereof.
- the polymer may, for example, be present in an amount of from 0.1 to 10 wt.-%, preferably from 0.5 to 5 wt.-%, based on the total weight of the oral care formulation.
- the oral care formulation comprises an anionic polymer.
- the anionic polymer is preferably selected from polycarboxylates, polyacrylic acids, polyacrylates, polyphosphonic acids, cross-linked carboxyvinyl copolymers, and mixtures thereof.
- the anionic polymer may, for example, be present in an amount of from 1 to 20 wt.-%, preferably from 5 to 15 wt.-%, based on the total weight of the oral care formulation.
- the oral care formulation comprises a thickening agent.
- the thickening agent is preferably selected from silica thickening agents, carboxy vinyl polymers, carrageenan, hydroxyethyl cellulose, salts of cellulose ethers such as sodium carboxymethyl cellulose or sodium carboxymethyl hydroxyethyl cellulose, karaya, gum arabic, gum tragacanth, colloidal magnesium aluminum silicate, and mixtures thereof.
- the thickening agent may, for example, be present in an amount of from 0.1 to 10 wt.-%, preferably from 0.5 to 5 wt.-%, based on the total weight of the oral care formulation.
- the oral care formulation comprises a foaming agent.
- the foaming agent is preferably selected from polyethylene glycol, alginate polymers, and mixtures thereof.
- the foaming agent may, for example, be present in an amount of from 0.1 to 20 wt.-%, preferably from 1 to 10 wt.-%, based on the total weight of the oral care formulation.
- the oral care formulation comprises a surfactant.
- the surfactant may, for example, be present in an amount of from 0.1 to 20 wt.-%, preferably from 1 to 10 wt.-%, based on the total weight of the oral care formulation.
- the surfactant is an anionic surfactant.
- the anionic surfactant is preferably selected from alkyl sulfates, for example sodium lauryl sulfate, alkyl ether sulfates, for example sodium laureth-2 sulfate, alkyl aryl sulfonates, for example sodium lauryl benzene sulfonate, alkyl sulfoacetates, for example sodium lauryl sulfoacetate, and mixtures thereof.
- the surfactant is a sulfur-free anionic surfactant.
- the sulfur-free anionic surfactant is preferably selected from taurates, for example sodium methyl cocoyl taurate, glycinates, for example sodium cocoyl glycinate, sarcosinates, for example sodium lauroyl sarcosinate, quaternary ammonium compounds, for example benzalkonium chloride or cetylpyridinium chloride, and mixtures thereof.
- the surfactant is a non-ionic surfactant.
- the surfactant is a glucamide.
- the surfactant is a glucamide of Formula X: wherein R is selected from saturated or unsaturated hydrocarbon chains having 5 to 23 carbon atoms.
- R in Formula (X) is selected from saturated or unsaturated hydrocarbon chains having 7 to 17 carbon atoms.
- glucamides of Formula (X) are capryloyl/caproyl methyl glucamide, lauroyl/myristoyl methyl glucamide, cocoyl methyl glucamide, oleyl methyl glucamide, or mixtures thereof.
- Such glucamides are commercially available from Clariant (GlucoTain® Clear, GlucoTain® Plus, GlucoTain® Flex, GlucoTain® Care, GlucoTain® Sense).
- glucamides of Formula (X) are N-9-decenoyl-N- methylglucamine, N-9-dodecenoyl-N-methylglucamine, or mixtures thereof.
- the surfactant is an alkyl polyglycoside (APG), preferably an alkyl polyglucoside.
- APG alkyl polyglycoside
- the surfactant is a zwitterionic surfactant, for example a betaine surfactant, for example cocam idopropyl betaine. In one embodiment, the surfactant is a cationic surfactant.
- the oral care formulation comprises a buffer or pH adjusting agent.
- the oral care formulation has a pH in the range of from 4 to 8, preferably from 4.5 to 7.5, more preferably from 5 to 7, particularly preferably from 5 to 6, also particularly preferably from 5.5 to 6.5, also particularly preferably from 6 to 7.
- the oral care formulation is a toothpaste, and the toothpaste has a pH in the range of from 4 to 8, preferably from 4.5 to 7.5, more preferably from 5 to 7, particularly preferably from 5 to 6, also particularly preferably from 5.5 to 6.5, also particularly preferably from 6 to 7.
- the oral care formulation comprises a flavoring agent, sweetening agent, and/or pigment or dye.
- flavors are mint, peppermint, spearmint, Wintergreen, menthol, or strawberry.
- An example of a sweetening agent is sodium saccharin.
- pigments are titanium dioxide or zinc oxide.
- the oral care formulation may, for example, be prepared by mixing its ingredients.
- the present invention also relates to compound X selected from compounds of Formula (I) wherein R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof, glyceryl ethers, sorbitan esters, and isosorbide esters for use in reducing the effects of dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
- R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof, glyceryl ethers, sorbitan esters, and isosorbide esters for use in reducing the effects of dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
- microorganisms examples include Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis.
- Preferred microorganisms are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L acidophilus).
- the dental caries causing microorganisms are dental caries causing bacteria.
- the dental plaque causing microorganisms are dental plaque causing bacteria.
- the gingivitis causing microorganisms are gingivitis causing bacteria.
- a preferred embodiment relates to compound X selected from compounds of Formula (I) wherein R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof, glyceryl ethers, sorbitan esters, and isosorbide esters for use in reducing the effects of dental caries causing bacteria, dental plaque causing bacteria or gingivitis causing bacteria.
- bacteria examples include Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis.
- Preferred bacteria are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L acidophilus).
- the present invention also relates to an oral care formulation as defined herein for use in reducing the effects of dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
- microorganisms examples include Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis.
- Preferred microorganisms are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L. acidophilus).
- the dental caries causing microorganisms are dental caries causing bacteria.
- the dental plaque causing microorganisms are dental plaque causing bacteria.
- the gingivitis causing microorganisms are gingivitis causing bacteria.
- a preferred embodiment relates to an oral care formulation as defined herein for use in reducing the effects of dental caries causing bacteria, dental plaque causing bacteria or gingivitis causing bacteria.
- examples of such bacteria are Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis.
- Preferred bacteria are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L acidophilus).
- the present invention also relates to compound X selected from compounds of Formula (I) wherein R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof, glyceryl ethers, sorbitan esters, and isosorbide esters for use in the prevention or treatment of dental caries, dental plaque or gingivitis.
- R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof, glyceryl ethers, sorbitan esters, and isosorbide esters for use in the prevention or treatment of dental caries, dental plaque or gingivitis.
- microorganisms examples include Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis.
- Preferred microorganisms are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L. acidophilus).
- the dental caries causing microorganisms are dental caries causing bacteria.
- the dental plaque causing microorganisms are dental plaque causing bacteria.
- the gingivitis causing microorganisms are gingivitis causing bacteria.
- a preferred embodiment relates to compound X selected from compounds of Formula (I) wherein R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof, glyceryl ethers, sorbitan esters, and isosorbide esters for use in the prevention or treatment of dental caries, dental plaque or gingivitis.
- bacteria examples include Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis.
- Preferred bacteria are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L acidophilus).
- the present invention also relates to an oral care formulation as defined herein for use in the prevention or treatment of dental caries, dental plaque or gingivitis.
- microorganisms examples include Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis.
- Preferred microorganisms are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L. acidophilus).
- the dental caries causing microorganisms are dental caries causing bacteria.
- the dental plaque causing microorganisms are dental plaque causing bacteria.
- the gingivitis causing microorganisms are gingivitis causing bacteria.
- a preferred embodiment relates to an oral care formulation as defined herein for use in the prevention or treatment of dental caries, dental plaque or gingivitis.
- bacteria examples include Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis.
- Preferred bacteria are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L acidophilus).
- the present invention also relates to a method of reducing the effects of dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms, wherein the method comprises contacting the dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms with compound X as defined herein or an oral care formulation as defined herein.
- microorganisms are Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis.
- Preferred microorganisms are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L. acidophilus).
- the dental caries causing microorganisms are dental caries causing bacteria.
- the dental plaque causing microorganisms are dental plaque causing bacteria.
- the gingivitis causing microorganisms are gingivitis causing bacteria.
- a preferred embodiment relates to a method of reducing the effects of dental caries causing bacteria, dental plaque causing bacteria or gingivitis causing bacteria, wherein the method comprises contacting the dental caries causing bacteria, dental plaque causing bacteria or gingivitis causing bacteria with compound X as defined herein or an oral care formulation as defined herein.
- examples of such bacteria are Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis.
- Preferred bacteria are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L acidophilus).
- the present invention also relates to a method of prevention or treatment of dental caries, dental plaque or gingivitis, wherein the method comprises contacting the oral cavity of a subject in need thereof with compound X as defined herein or an oral care formulation as defined herein.
- the present invention also relates to the use of compound X as defined herein or an oral care formulation as defined herein for the prevention or treatment of dental caries, dental plaque or gingivitis.
- Molecular weight or “M.Wt.” or “MW’ and grammatical equivalents mean the number average molecular weight.
- Viscosity is measured at 25°C using a HAAKE Rotation Viscometer VT 550 with cooling/heating vessel and sensor systems according to DIN 53019 at a shear rate of 12.9 s- 1 .
- Water-soluble refers to any material that is sufficiently soluble in water to form a clear solution to the naked eye at a concentration of 0.1 % by weight of the material in water at 25°C.
- water-insoluble refers to any material that is not “water-soluble”.
- “Dry” or “substantially dry” means comprising less than 5 %, less than 3 %, less than 2 %, less than 1 %, or about 0 % of any compound or composition being in liquid form when measured at 25°C at ambient conditions. Such compounds or compositions being in liquid form include water, oils, organic solvents and other wetting agents. 'Anhydrous" means that the composition comprises less than 5 %, less than 3 %, less than 2 %, less than 1 %, or about 0 % water by total weight of the composition.
- “Substantially free from” or “substantially free of” means less than 1 %, or less than 0.8 %, or less than 0.5 %, or less than 0.3 %, or about 0 %, by total weight of the composition.
- “Derivatives” includes but is not limited to amide, ether, ester, amino, carboxyl, acetyl, acid, salt and/or alcohol derivatives of a given compound. In at least one embodiment, “derivatives thereof” means the amide, ether, ester, amino, carboxyl, acetyl, acid, salt and alcohol derivatives.
- Capryloyl/Caproyl Anhydro Methyl Glucamide is a mixture of compounds of Formula (I) wherein R is -(CFhjsCHs and compounds of Formula (I) wherein R is - (CH 2 ) 6 CH 3 .
- Velsan® EHG is commercially available from Clariant. Chemical name: Ethylhexylglycerin.
- Example 1 Microbiological test
- microbiological test was carried out according to BS EN 1040:2005.
- sample solutions 1 . 1 %, 2%, 3% and 5% sample solutions were prepared in sterilized tap water.
- Example 2 Examples of toothpaste formulations (amounts are given in wt-%)
- Example 3 Examples of toothpaste formulations (amounts are given in wt-%)
- Example 4 Examples of toothpaste formulations (amounts are given in wt-%)
- Example 5 Examples of toothpaste formulations (amounts are given in wt-%)
- Example 6 Examples of toothpaste formulations (amounts are given in wt-%)
- Example 7 Example of a mouthwash formulation (amounts are given in wt-%)
- the reducing effect of toothpaste samples on biofilm-forming bacteria such as streptococci was tested over a period of up to 5 minutes.
- a biofilm of the test bacteria (Streptococcus mutans) was cultured, and then the toothpaste solution (40% toothpaste in tap water) was applied to the biofilm. After the elapsed time, the reducing effect was quantified by determining the number of germs.
- a control with tap water serves as a reference to rule out that the tap water influences the bacteria.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to the use of compound X selected from compounds of Formula (I) wherein R is selected from saturated hydrocarbon chains having to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof, glyceryl ethers, sorbitan esters, and isosorbide esters as an antimicrobial agent against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
Description
ANTIMICROBIAL COMPOUNDS FOR ORAL CARE
The present invention relates to the use of certain compounds as antimicrobial agents against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms, as well as to oral care formulations. The present invention also relates to certain compounds for use in reducing the effects of dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms, to certain compounds for use in the prevention or treatment of dental caries, dental plaque or gingivitis, to oral care formulations for use in reducing the effects of dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms, and to oral care formulations for use in the prevention or treatment of dental caries, dental plaque or gingivitis.
Oral care is important for general hygiene and overall well-being. Oral care includes, among others, brushing the teeth with toothpaste and rinsing the mouth with mouthwash.
Dental caries is caused by the production of acid by certain bacteria, including Streptococcus mutans (S. mutans). S. mutans produces sticky, adhesive glucans and fructans from fermentable sugars, particularly sucrose, which promote the adhesion of bacteria to the oral surfaces.
Dental plaque is a sticky biofilm or mass of bacteria that is commonly found on the teeth, along the gum line, and below the gum line margins. Dental plaque can give rise to dental caries and gingivitis.
There is an ongoing need for antimicrobial agents that can be used in oral care formulations.
It has been found that certain compounds are useful as antimicrobial agents against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
Accordingly, the present invention relates to the use of compound X selected from compounds of Formula (I)
wherein R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof, glyceryl ethers, sorbitan esters, and isosorbide esters as an antimicrobial agent against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
Advantageously, the compounds used in the present invention have a high renewable carbon content, i.e. they are sustainable. The compounds used in the present invention can be incorporated into an oral care formulation.
According to the invention, compound X selected from compounds of Formula (I)
wherein R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof,
glyceryl ethers, sorbitan esters, and isosorbide esters is used as an antimicrobial agent against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
According to the invention, compound X is selected from compounds of Formula (I)
wherein R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof, glyceryl ethers, sorbitan esters, and isosorbide esters.
In one embodiment, compound X selected from compounds of Formula (I)
wherein R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof, is used as an antimicrobial agent against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
In one embodiment, compound X is selected from compounds of Formula (I)
wherein R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof.
Preferably, R in Formula (I) is selected from saturated hydrocarbon chains having 5 to 17 carbon atoms, unsaturated hydrocarbon chains having 5 to 17 carbon atoms, and mixtures thereof.
More preferably, R in Formula (I) is selected from saturated hydrocarbon chains having 5 to 13 carbon atoms, unsaturated hydrocarbon chains having 5 to 13 carbon atoms, and mixtures thereof.
Particularly preferably, R in Formula (I) is selected from saturated hydrocarbon chains having 7 to 9 carbon atoms, unsaturated hydrocarbon chains having 7 to 9 carbon atoms, and mixtures thereof.
In at least one embodiment, R in Formula (I) is selected from -(CF^eCHs, - (CH2)8CH3, and mixtures thereof; or R in Formula (I) is selected from -(CH2)-IOCH3, -(CH2)i2CH3, and mixtures thereof; or R in Formula (I) is selected from - (CH2)?CH=CH2, -(CH2)7CH=CHCH2CH3, and mixtures thereof; or the R-C=O residue in Formula (I) is derived from coconut fatty acids; or the R-C=O residue in Formula (I) is derived from soybean fatty acids.
In at least one embodiment, R in Formula (I) is selected from -(CF^eCF , - (CH2)8CH3, and mixtures thereof. In at least one embodiment, R in Formula (I) is selected from -(CH2)-IOCH3, -(CH2)i2CH3, and mixtures thereof. In at least one embodiment, R in Formula (I) is selected from -(CH2)?CH=CH2, - (CH2)7CH=CHCH2CH3, and mixtures thereof. In at least one embodiment, the R-
C=O residue in Formula (I) is derived from coconut fatty acids. In at least one embodiment, the R-C=O residue in Formula (I) is derived from soybean fatty acids.
As used herein, the expression “the R-C=O residue in Formula (I) is derived from coconut fatty acids” preferably means that the carbon chain length distribution in the R-C=O residue in Formula (I) corresponds to the carbon chain length distribution of the fatty acids (e.g. bound as triglycerides) in coconut oil.
As used herein, the expression “the R-C=O residue in Formula (I) is derived from soybean fatty acids” preferably means that the carbon chain length distribution in the R-C=O residue in Formula (I) corresponds to the carbon chain length distribution of the fatty acids (e.g. bound as triglycerides) in soybean oil.
Preferably, the weight ratio of compounds according to Formula (I) wherein R is - (CH2)eCH3 and compounds according to Formula (I) wherein R is -(CF^sCHs is from 1 :9 to 9:1 , preferably from 3:7 to 7:3.
Preferably, the weight ratio of compounds according to Formula (I) wherein R is - (CH2)IOCH3 and compounds according to Formula (I) wherein R is -(CH2)i2CH3 is from 1 :9 to 9:1 , preferably from 3:7 to 7:3.
Preferably, the weight ratio of compounds according to Formula (I) wherein R is - (CH2)?CH=CH2 and compounds according to Formula (I) wherein R is - (CH2)?CH=CHCH2CH3 is from 1 :9 to 9:1 , preferably from 3:7 to 7:3.
Advantageously, the compound of Formula (I) is soluble in water. Therefore, the compound of Formula (I) is suitable for use in mouth wash formulations.
Compounds of Formula (I) are described in, e.g., WO 2018/002100 and EP application number EP21200587.0.
In one embodiment, compound X selected from glyceryl ethers is used as an
antimicrobial agent against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
In one embodiment, compound X is selected from glyceryl ethers.
Preferably, the glyceryl ethers are mono- or diethers of glycerin and one or more C6-C20 fatty alcohols. More preferably, the glyceryl ethers are mono- or diethers of glycerin and one or more C8-C14 fatty alcohols. Particularly preferably, the glyceryl ethers are monoethers of glycerin and one or more C8 fatty alcohols.
In at least one embodiment, the glyceryl ethers are selected from ethylhexylglycerin, methylheptylglycerin, caprylyl glyceryl ether, and mixtures thereof.
In one embodiment, compound X selected from sorbitan esters and isosorbide esters is used as an antimicrobial agent against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
In one embodiment, compound X is selected from sorbitan esters and isosorbide esters.
In one embodiment, compound X selected from sorbitan esters is used as an antimicrobial agent against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
In one embodiment, compound X is selected from sorbitan esters.
Preferably, the sorbitan esters are mono-, di- or triesters of sorbitan and one or more C6-C20 fatty acids. More preferably, the sorbitan esters are mono- or diesters of sorbitan and one or more C8-C14 fatty acids. Particularly preferably, the sorbitan esters are mono- or diesters of sorbitan and caprylic acid.
Preferably, the sorbitan esters are selected from sorbitan caprylate, sorbitan stearate, sorbitan olivate, sorbitan oleate, sorbitan caprate, sorbitan laurate, sorbitan myristate, sorbitan caproate, and mixtures thereof. Particularly preferably, the sorbitan ester is sorbitan caprylate.
In one embodiment, compound X selected from isosorbide esters is used as an antimicrobial agent against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
In one embodiment, compound X is selected from isosorbide esters.
Preferably, the isosorbide esters are mono- or diesters of isosorbide and one or more C6-C20 fatty acids. More preferably, the isosorbide esters are mono- or diesters of isosorbide and one or more C8-C14 fatty acids. Particularly preferably, the isosorbide esters are mono- or diesters of isosorbide and caprylic acid.
Preferably, the isosorbide esters are selected from isosorbide caprylate, isosorbide stearate, isosorbide olivate, isosorbide oleate, isosorbide caprate, isosorbide laurate, isosorbide myristate, isosorbide caproate, and mixtures thereof. Particularly preferably, the isosorbide ester is isosorbide caprylate.
Advantageously, compound X is suitable for use in toothpaste formulations.
According to the invention, compound X as defined herein is used as an antimicrobial agent against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms. Examples of such microorganisms are Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis. Preferred microorganisms are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L acidophilus).
In a preferred embodiment, the dental caries causing microorganisms are dental
caries causing bacteria. In a preferred embodiment, the dental plaque causing microorganisms are dental plaque causing bacteria. In a preferred embodiment, the gingivitis causing microorganisms are gingivitis causing bacteria.
In a preferred embodiment, compound X as defined herein is used as an antibacterial agent against dental caries causing bacteria, dental plaque causing bacteria or gingivitis causing bacteria. Examples of such bacteria are Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis. Preferred bacteria are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L acidophilus).
Streptococcus mutans, Streptococcus sanguinis and Streptococcus sobrinus are film formers. Streptococcus gordonii is a film former and an acid former.
Lactobacillus acidophilus is an acid former. It attacks the dental enamel. Fusobacterium nucleatum is a film former. Porphyromonas gingivalis is responsible for periodentosis.
Optionally, compound X as defined herein is used in combination with a further antimicrobial agent.
In at least one embodiment, the antimicrobial agent is selected from the group consisting of: aromatic alcohols, organic acids and salts thereof, hydroxamic acids and salts thereof, hydroxyacetophenone, compounds according to Formula (P), alkyl diols, halogenated compounds, isothiazolinones, and mixtures thereof; wherein Formula (P) is as follows:
O‘X + wherein
R1 ’ is H, an unsubstituted or halogen-substituted, branched or unbranched C-i- C2o-alkyl radical, an unsubstituted or halogen-substituted Cs-Cs-cycloalkyl radical, an unsubstituted or halogen-substituted Ce-C -aryl radical or an unsubstituted or halogen-substituted, branched or unbranched C7-C20- aralkyl radical;
R2’ is 0 or S;
R3’ is H or a Ci-C4-alkyl radical;
X+ is a cation.
Preferably, R3' is methyl.
In at least one embodiment, the aromatic alcohols are selected from the group consisting of benzyl alcohol, phenoxyethanol, veratryl alcohol, propylene phenoxyethanol, phenethyl alcohol, phenylpropanol, vanillin, 2-methyl-1 -phenyl- 2-propanol, and mixtures thereof.
In at least one embodiment, the organic acids and salts thereof are selected from the group consisting of benzoic acid, sorbic acid, dehydroacetic acid, lactic acid, salicylic acid, p-anisic acid, undecylenic acid, glycolic acid, propionic acid, levulinic acid, and mixtures thereof.
In at least one embodiment, the hydroxamic acid is selected from hydroxamic acids of Formula (III)
wherein R1 is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof.
Preferably, R1 in Formula (III) is selected from saturated hydrocarbon chains having 5 to 17 carbon atoms, unsaturated hydrocarbon chains having 5 to 17 carbon atoms, and mixtures thereof. More preferably, R1 in Formula (III) is
selected from saturated hydrocarbon chains having 5 to 13 carbon atoms, unsaturated hydrocarbon chains having 5 to 13 carbon atoms, and mixtures thereof. Particularly preferably, R1 in Formula (III) is selected from saturated hydrocarbon chains having 7 carbon atoms, unsaturated hydrocarbon chains having 7 carbon atoms, and mixtures thereof.
Preferred hydroxamic acids are selected from caprylhydroxamic acid, hexanohydroxamic acid, caprohydroxamic acid, laurohydroxamic acid, and mixtures thereof. A particularly preferred hydroxamic acid is caprylhydroxamic acid. Caprylhydroxamic acid may also be referred to as caprylohydroxamic acid or octanohydroxamic acid. Hydroxamic acids are described in, e.g., EP2224973.
Examples of salts of hydroxamic acids are alkali metal salts of hydroxamic acids (e.g. sodium salts of hydroxamic acids or potassium salts of hydroxamic acids) or alkaline earth metal salts of hydroxamic acids (e.g. magnesium salts of hydroxamic acids or calcium salts of hydroxamic acids).
In at least one embodiment, the compound according to Formula (P) is selected from the group consisting of 2-hydroxypyridine-N-oxide, 2-pyridinethiol-1 -oxide and salts thereof, 1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2(1 H)-pyridone and salts thereof (preferably the monoethanolamine salt), and mixtures thereof. Formula (P) discloses and encompasses the tautomeric equivalents of these compounds, since an equilibrium always exists. In at least one embodiment, the compound according to Formula (P) is piroctone olamine (Octopirox).
In at least one embodiment, the alkyl diols are selected from the group consisting of 1 ,2-pentanediol, 1 ,2-hexanediol, 1 ,6-hexanediol, 1 ,2-octanediol, 1 ,2- heptanediol, 1 ,2-decanediol, methylpropanediol, and mixtures thereof.
In at least one embodiment, the halogenated compounds are selected from the group consisting of chlorhexidine and salts thereof, triclosan, chlorphenesin, trichlorcarban, chloroxylenol, bronopol, climbazole, and mixtures thereof.
In at least one embodiment, the isothiazolinones are selected from the group consisting of methylisothiazolinone, methylchloroisothiazolinone, benzylisothiazolinone, and mixtures thereof.
In at least one embodiment, the antimicrobial agent is selected from the group consisting of aromatic alcohols, organic acids and salts thereof, hydroxamic acids and salts thereof, hydroxyacetophenone, hydroxypyridones, alkyl diols, halogenated compounds, isothiazolinones, and mixtures thereof.
In at least one embodiment, the antimicrobial agent is selected from the group consisting of phenoxyethanol, benzyl alcohol, phenethyl alcohol, benzoic acid and salts thereof, caprylhydroxamic acid, hydroxyacetophenone, piroctone olamine, and mixtures thereof.
In a preferred embodiment, the antimicrobial agent is 1 ,2-octanediol, in particular bio-based 1 ,2-octanediol, for example bio-1 ,2-octanediol as disclosed in WO 2019/152569.
Suitable antimicrobial agents are also listed in Annex V (updated on 28/09/2022) of the REGULATION (EC) No 1223/2009 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 30 November 2009 on cosmetic products.
Preferably, the weight ratio of compound X as defined herein to the further antimicrobial agent, if present, is from 20:1 to 1 :20, more preferably from 15:1 to 1 :15, even more preferably from 10:1 to 1 :10, particularly preferably from 5:1 to 1 :5, for example 1 :1.
The present invention also relates to an oral care formulation comprising from 0.1 to 20 wt.-%, preferably from 0.2 to 10 wt.-%, more preferably from 0.3 to 5 wt.-%, even more preferably from 0.4 to 3 wt.-%, particularly preferably from 0.5 to 2 wt.-%, based on the total weight of the oral care formulation, of compound X as defined herein.
In a preferred embodiment, the oral care formulation is selected from the group consisting of toothpaste, oral gel, mouth wash, tooth powder and chewing gum. In a more preferred embodiment, the oral care formulation is selected from the group consisting of toothpaste and mouth wash. In a particularly preferred embodiment, the oral care formulation is a toothpaste. In another particularly preferred embodiment, the oral care formulation is a mouth wash.
In one embodiment, the oral care formulation comprises a solvent. The solvent is preferably selected from water, propylene glycol, isopropanol, and mixtures thereof.
In one embodiment, the oral care formulation comprises a humectant. The humectant is preferably selected from sorbitol, glycerol, xylitol, and mixtures thereof.
The humectant may, for example, be present in an amount of from 10 to 70 wt.-%, preferably from 30 to 60 wt.-%, for example from 40 to 55 wt.-%, based on the total weight of the oral care formulation.
In one embodiment, the oral care formulation comprises an abrasive. The abrasive is preferably selected from silica abrasives, hydrated silica, hydrated alumina, calcium abrasives, tricalcium phosphate, hydroxyapatite, dicalcium phosphate dihydrate, calcium pyrophosphate, calcium carbonate, sodium metaphosphate, potassium metaphosphate, aluminum silicate, calcined alumina, bentonite, sodium bicarbonate, and mixtures thereof.
The abrasive may, for example, be present in an amount of from 10 to 30 wt.-%, preferably from 15 to 25 wt.-%, based on the total weight of the oral care formulation.
In one embodiment, the oral care formulation comprises an anticalculus agent.
The anticalculus agent is preferably selected from phosphates, polyphosphates, pyrophosphates, e.g. tetrasodium pyrophosphate, polyaminopropanesulfonic acid, hexametaphosphate salts, zinc citrate trihydrate, polypeptides, polyolefin sulfonates, polyolefin phosphates, diphosphonates, and mixtures thereof.
The anticalculus agent may, for example, be present in an amount of from 0.01 to 20 wt.-%, preferably from 0.1 to 10 wt.-%, based on the total weight of the oral care formulation.
In one embodiment, the oral care formulation comprises a fluoride source. The fluoride source is preferably selected from stannous fluoride, sodium fluoride, potassium fluoride, sodium monofluorophosphate, sodium fluorosilicate, ammonium fluorosilicate, amine fluoride, ammonium fluoride, calcium fluoride, aluminum fluoride, fluorohydroxyapatite, and mixtures thereof. The fluoride source is preferably selected from stannous fluoride, sodium fluoride, potassium fluoride, sodium monofluorophosphate, sodium fluorosilicate, ammonium fluorosilicate, amine fluoride, ammonium fluoride, and mixtures thereof.
The fluoride source may, for example, be present in an amount of from 0.01 to 10 wt.-%, preferably from 0.1 to 2 wt.-%, based on the total weight of the oral care formulation. The fluoride source may, for example, be present in an amount of from 0.01 to 1 wt.-%, preferably from 0.02 to 0.5 wt.-%, more preferably from 0.03 to 0.3 wt.-%, even more preferably from 0.04 to 0.2 wt.-%, particularly preferably from 0.05 to 0.15 wt.-%, based on the total weight of the oral care formulation. The fluoride source may, for example, be present in an amount of from 0.01 to 0.15 wt.-%, preferably from 0.02 to 0.15 wt.-%, more preferably from 0.03 to 0.15 wt.-%, even more preferably from 0.04 to 0.15 wt.-%, particularly preferably from 0.05 to 0.15 wt.-%, based on the total weight of the oral care formulation. In a preferred embodiment, the oral care formulation is a toothpaste, and the toothpaste comprises a fluoride source.
In one embodiment, the oral care formulation comprises a polymer. The polymer is preferably selected from polyethylene glycols, polysaccharides, for example cellulose derivatives, for example carboxymethyl cellulose, hydroxymethyl cellulose, ethyl cellulose, microcrystalline cellulose, or polysaccharide gums, for example xanthan gum, guar gum or carrageenan gum, or polyacrylates or polymers based on N-vinylpyrrolidone, and mixtures thereof.
The polymer may, for example, be present in an amount of from 0.1 to 10 wt.-%, preferably from 0.5 to 5 wt.-%, based on the total weight of the oral care
formulation.
In one embodiment, the oral care formulation comprises an anionic polymer. The anionic polymer is preferably selected from polycarboxylates, polyacrylic acids, polyacrylates, polyphosphonic acids, cross-linked carboxyvinyl copolymers, and mixtures thereof.
The anionic polymer may, for example, be present in an amount of from 1 to 20 wt.-%, preferably from 5 to 15 wt.-%, based on the total weight of the oral care formulation.
In one embodiment, the oral care formulation comprises a thickening agent. The thickening agent is preferably selected from silica thickening agents, carboxy vinyl polymers, carrageenan, hydroxyethyl cellulose, salts of cellulose ethers such as sodium carboxymethyl cellulose or sodium carboxymethyl hydroxyethyl cellulose, karaya, gum arabic, gum tragacanth, colloidal magnesium aluminum silicate, and mixtures thereof.
The thickening agent may, for example, be present in an amount of from 0.1 to 10 wt.-%, preferably from 0.5 to 5 wt.-%, based on the total weight of the oral care formulation.
In one embodiment, the oral care formulation comprises a foaming agent. The foaming agent is preferably selected from polyethylene glycol, alginate polymers, and mixtures thereof.
The foaming agent may, for example, be present in an amount of from 0.1 to 20 wt.-%, preferably from 1 to 10 wt.-%, based on the total weight of the oral care formulation.
In one embodiment, the oral care formulation comprises a surfactant. The surfactant may, for example, be present in an amount of from 0.1 to 20 wt.-%, preferably from 1 to 10 wt.-%, based on the total weight of the oral care formulation.
In one embodiment, the surfactant is an anionic surfactant. The anionic surfactant
is preferably selected from alkyl sulfates, for example sodium lauryl sulfate, alkyl ether sulfates, for example sodium laureth-2 sulfate, alkyl aryl sulfonates, for example sodium lauryl benzene sulfonate, alkyl sulfoacetates, for example sodium lauryl sulfoacetate, and mixtures thereof.
In one embodiment, the surfactant is a sulfur-free anionic surfactant.
The sulfur-free anionic surfactant is preferably selected from taurates, for example sodium methyl cocoyl taurate, glycinates, for example sodium cocoyl glycinate, sarcosinates, for example sodium lauroyl sarcosinate, quaternary ammonium compounds, for example benzalkonium chloride or cetylpyridinium chloride, and mixtures thereof.
In one embodiment, the surfactant is a non-ionic surfactant. In one embodiment, the surfactant is a glucamide. In one embodiment, the surfactant is a glucamide of Formula X:
wherein R is selected from saturated or unsaturated hydrocarbon chains having 5 to 23 carbon atoms. Preferably, R in Formula (X) is selected from saturated or unsaturated hydrocarbon chains having 7 to 17 carbon atoms. Also preferably, the R-C=O residue in Formula (X) is derived from caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, coconut fatty acids, or mixtures thereof. Also preferably, the R-C=O residue in Formula (X) is derived from 9-decenoic acid, 9-dodecenoic acid, or mixtures thereof.
Particularly preferred glucamides of Formula (X) are capryloyl/caproyl methyl glucamide, lauroyl/myristoyl methyl glucamide, cocoyl methyl glucamide, oleyl methyl glucamide, or mixtures thereof. Such glucamides are commercially available from Clariant (GlucoTain® Clear, GlucoTain® Plus, GlucoTain® Flex, GlucoTain® Care, GlucoTain® Sense).
Also particularly preferred glucamides of Formula (X) are N-9-decenoyl-N-
methylglucamine, N-9-dodecenoyl-N-methylglucamine, or mixtures thereof.
In one embodiment, the surfactant is an alkyl polyglycoside (APG), preferably an alkyl polyglucoside.
In one embodiment, the surfactant is a zwitterionic surfactant, for example a betaine surfactant, for example cocam idopropyl betaine. In one embodiment, the surfactant is a cationic surfactant.
In one embodiment, the oral care formulation comprises a buffer or pH adjusting agent. In a preferred embodiment, the oral care formulation has a pH in the range of from 4 to 8, preferably from 4.5 to 7.5, more preferably from 5 to 7, particularly preferably from 5 to 6, also particularly preferably from 5.5 to 6.5, also particularly preferably from 6 to 7. In a preferred embodiment, the oral care formulation is a toothpaste, and the toothpaste has a pH in the range of from 4 to 8, preferably from 4.5 to 7.5, more preferably from 5 to 7, particularly preferably from 5 to 6, also particularly preferably from 5.5 to 6.5, also particularly preferably from 6 to 7.
In one embodiment, the oral care formulation comprises a flavoring agent, sweetening agent, and/or pigment or dye. Examples of flavors are mint, peppermint, spearmint, Wintergreen, menthol, or strawberry. An example of a sweetening agent is sodium saccharin. Examples of pigments are titanium dioxide or zinc oxide.
The oral care formulation may, for example, be prepared by mixing its ingredients.
The present invention also relates to compound X selected from compounds of Formula (I)
wherein R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof, glyceryl ethers, sorbitan esters, and isosorbide esters for use in reducing the effects of dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
Examples of such microorganisms are Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis. Preferred microorganisms are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L acidophilus).
In a preferred embodiment, the dental caries causing microorganisms are dental caries causing bacteria. In a preferred embodiment, the dental plaque causing microorganisms are dental plaque causing bacteria. In a preferred embodiment, the gingivitis causing microorganisms are gingivitis causing bacteria.
A preferred embodiment relates to compound X selected from compounds of Formula (I)
wherein R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof, glyceryl ethers, sorbitan esters, and isosorbide esters for use in reducing the effects of dental caries causing bacteria, dental plaque causing bacteria or gingivitis causing bacteria.
Examples of such bacteria are Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis. Preferred bacteria are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L acidophilus).
The present invention also relates to an oral care formulation as defined herein for use in reducing the effects of dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
Examples of such microorganisms are Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis. Preferred microorganisms are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L. acidophilus).
In a preferred embodiment, the dental caries causing microorganisms are dental caries causing bacteria. In a preferred embodiment, the dental plaque causing microorganisms are dental plaque causing bacteria. In a preferred embodiment, the gingivitis causing microorganisms are gingivitis causing bacteria.
A preferred embodiment relates to an oral care formulation as defined herein for use in reducing the effects of dental caries causing bacteria, dental plaque causing bacteria or gingivitis causing bacteria.
Examples of such bacteria are Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis. Preferred bacteria are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L acidophilus).
The present invention also relates to compound X selected from compounds of Formula (I)
wherein R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof, glyceryl ethers, sorbitan esters, and isosorbide esters for use in the prevention or treatment of dental caries, dental plaque or gingivitis.
Examples of such microorganisms are Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis. Preferred microorganisms are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L. acidophilus).
In a preferred embodiment, the dental caries causing microorganisms are dental caries causing bacteria. In a preferred embodiment, the dental plaque causing microorganisms are dental plaque causing bacteria. In a preferred embodiment, the gingivitis causing microorganisms are gingivitis causing bacteria.
A preferred embodiment relates to compound X selected from
compounds of Formula (I)
wherein R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof, glyceryl ethers, sorbitan esters, and isosorbide esters for use in the prevention or treatment of dental caries, dental plaque or gingivitis.
Examples of such bacteria are Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis. Preferred bacteria are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L acidophilus).
The present invention also relates to an oral care formulation as defined herein for use in the prevention or treatment of dental caries, dental plaque or gingivitis.
Examples of such microorganisms are Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis. Preferred microorganisms are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L. acidophilus).
In a preferred embodiment, the dental caries causing microorganisms are dental caries causing bacteria. In a preferred embodiment, the dental plaque causing microorganisms are dental plaque causing bacteria. In a preferred embodiment, the gingivitis causing microorganisms are gingivitis causing bacteria.
A preferred embodiment relates to an oral care formulation as defined herein for use in the prevention or treatment of dental caries, dental plaque or gingivitis.
Examples of such bacteria are Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis. Preferred bacteria are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L acidophilus).
The present invention also relates to a method of reducing the effects of dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms, wherein the method comprises contacting the dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms with compound X as defined herein or an oral care formulation as defined herein. Examples of such microorganisms are Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis. Preferred microorganisms are Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L. acidophilus).
In a preferred embodiment, the dental caries causing microorganisms are dental caries causing bacteria. In a preferred embodiment, the dental plaque causing microorganisms are dental plaque causing bacteria. In a preferred embodiment, the gingivitis causing microorganisms are gingivitis causing bacteria.
A preferred embodiment relates to a method of reducing the effects of dental caries causing bacteria, dental plaque causing bacteria or gingivitis causing bacteria, wherein the method comprises contacting the dental caries causing bacteria, dental plaque causing bacteria or gingivitis causing bacteria with compound X as defined herein or an oral care formulation as defined herein. Examples of such bacteria are Streptococcus mutans, Streptococcus sanguinis, Streptococcus sobrinus, Streptococcus gordonii, Lactobacillus acidophilus, Fusobacterium nucleatum or Porphyromonas gingivalis. Preferred bacteria are
Streptococcus mutans (S. mutans) or Lactobacillus acidophilus (L acidophilus).
The present invention also relates to a method of prevention or treatment of dental caries, dental plaque or gingivitis, wherein the method comprises contacting the oral cavity of a subject in need thereof with compound X as defined herein or an oral care formulation as defined herein.
The present invention also relates to the use of compound X as defined herein or an oral care formulation as defined herein for the prevention or treatment of dental caries, dental plaque or gingivitis.
In this document, the following definitions apply unless specifically stated otherwise. All percentages are by weight (w/w) of the total composition. All ratios are weight ratios. “wt.-%” means percentage by weight.
“Molecular weight” or “M.Wt.” or “MW’ and grammatical equivalents mean the number average molecular weight.
“Viscosity” is measured at 25°C using a HAAKE Rotation Viscometer VT 550 with cooling/heating vessel and sensor systems according to DIN 53019 at a shear rate of 12.9 s-1.
“Water-soluble” refers to any material that is sufficiently soluble in water to form a clear solution to the naked eye at a concentration of 0.1 % by weight of the material in water at 25°C. The term “water-insoluble” refers to any material that is not “water-soluble”.
“Dry” or “substantially dry” means comprising less than 5 %, less than 3 %, less than 2 %, less than 1 %, or about 0 % of any compound or composition being in liquid form when measured at 25°C at ambient conditions. Such compounds or compositions being in liquid form include water, oils, organic solvents and other wetting agents. 'Anhydrous" means that the composition comprises less than 5 %, less than 3 %, less than 2 %, less than 1 %, or about 0 % water by total weight
of the composition.
“Substantially free from” or “substantially free of” means less than 1 %, or less than 0.8 %, or less than 0.5 %, or less than 0.3 %, or about 0 %, by total weight of the composition.
“Derivatives” includes but is not limited to amide, ether, ester, amino, carboxyl, acetyl, acid, salt and/or alcohol derivatives of a given compound. In at least one embodiment, “derivatives thereof” means the amide, ether, ester, amino, carboxyl, acetyl, acid, salt and alcohol derivatives.
The examples which follow are intended to illustrate the subject matter of the invention without restricting it thereto.
Examples
Materials
Velsan® Flex is commercially available from Clariant. Chemical name: Capryloyl/Caproyl Anhydro Methyl Glucamide (and) Water, active content: 70 wt.- %. Capryloyl/Caproyl Anhydro Methyl Glucamide is a mixture of compounds of Formula (I) wherein R is -(CFhjsCHs and compounds of Formula (I) wherein R is - (CH2)6CH3.
Velsan® EHG is commercially available from Clariant. Chemical name: Ethylhexylglycerin.
Example 1 : Microbiological test
The microbiological test was carried out according to BS EN 1040:2005.
1 . 1 %, 2%, 3% and 5% sample solutions were prepared in sterilized tap water.
2. An inoculum suspension with Streptococcus mutans was prepared.
3. 1.0 ml sterilized tap water and 1.0 ml inoculum were placed in a test tube.
4. 8 ml of sample solution was added, a stopwatch was started, the mixture was homogenized.
5. 1 ml of solution was taken from the resulting solution after 2 minutes and a plate count was performed from it using standard pour plate method.
This was also done with a blank sample to prove that only the contained active substance is responsible for the reduction of Streptococcus mutans.
Example 2: Examples of toothpaste formulations (amounts are given in wt-%)
Example 3: Examples of toothpaste formulations (amounts are given in wt-%)
Example 8: Toothpaste against biofilm formers from the oral cavity
The reducing effect of toothpaste samples on biofilm-forming bacteria such as streptococci was tested over a period of up to 5 minutes. A biofilm of the test bacteria (Streptococcus mutans) was cultured, and then the toothpaste solution (40% toothpaste in tap water) was applied to the biofilm. After the elapsed time, the reducing effect was quantified by determining the number of germs. A control
with tap water serves as a reference to rule out that the tap water influences the bacteria.
The toothpastes were tested with and without the addition of Velsan Flex (2% and 3%).
Conclusion:
The addition of Velsan Flex leads to a reduction of the test bacteria.
Claims
1. Use of compound X selected from compounds of Formula (I)
wherein R is selected from saturated hydrocarbon chains having 5 to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof, glyceryl ethers, sorbitan esters, and isosorbide esters as an antimicrobial agent against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
2. The use according to claim 1 , wherein
R in Formula (I) is selected from saturated hydrocarbon chains having 5 to
17 carbon atoms, unsaturated hydrocarbon chains having 5 to 17 carbon atoms, and mixtures thereof, preferably is selected from saturated hydrocarbon chains having 5 to 13 carbon atoms, unsaturated hydrocarbon chains having 5 to 13 carbon atoms, and mixtures thereof, particularly preferably is selected from saturated hydrocarbon chains having 7 to 9 carbon atoms, unsaturated hydrocarbon chains having 7 to 9 carbon atoms, and mixtures thereof.
3. The use according to claim 1 or 2, wherein the glyceryl ethers are mono- or diethers of glycerin and one or more C6-C20 fatty alcohols, preferably
mono- or diethers of glycerin and one or more C8-C14 fatty alcohols, particularly preferably monoethers of glycerin and one or more C8 fatty alcohols.
4. The use according to any of claims 1 to 3, wherein the sorbitan esters are mono-, di- or triesters of sorbitan and one or more C6-C20 fatty acids, preferably mono- or diesters of sorbitan and one or more C8-C14 fatty acids, particularly preferably mono- or diesters of sorbitan and caprylic acid.
5. The use according to any of claims 1 to 4, wherein the sorbitan esters are selected from sorbitan caprylate, sorbitan stearate, sorbitan olivate, sorbitan oleate, sorbitan caprate, sorbitan laurate, sorbitan myristate, sorbitan caproate, and mixtures thereof, preferably is sorbitan caprylate.
6. The use according to any of claims 1 to 5, wherein the isosorbide esters are mono- or diesters of isosorbide and one or more C6-C20 fatty acids, preferably mono- or diesters of isosorbide and one or more C8-C14 fatty acids, particularly preferably mono- or diesters of isosorbide and caprylic acid.
7. The use according to any of claims 1 to 6, wherein the isosorbide esters are selected from isosorbide caprylate, isosorbide stearate, isosorbide olivate, isosorbide oleate, isosorbide caprate, isosorbide laurate, isosorbide myristate, isosorbide caproate, and mixtures thereof, preferably is isosorbide caprylate.
8. Compound X as defined in any of claims 1 to 7 for use in reducing the effects of dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
9. Compound X as defined in any of claims 1 to 7 for use in the prevention or treatment of dental caries, dental plaque or gingivitis.
10. An oral care formulation comprising from 0.1 to 20 wt.-%, preferably from 0.2 to 10 wt.-%, more preferably from 0.3 to 5 wt.-%, even more preferably from 0.4 to 3 wt.-%, particularly preferably from 0.5 to 2 wt.-%, based on the total weight of the oral care formulation, of compound X as defined in any of claims 1 to 7.
11 . The oral care formulation according to claim 10, wherein the oral care formulation is selected from the group consisting of toothpaste, oral gel, mouth wash, tooth powder and chewing gum.
12. An oral care formulation as defined in claim 10 or 11 for use in reducing the effects of dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
13. An oral care formulation as defined in claim 10 or 11 for use in the prevention or treatment of dental caries, dental plaque or gingivitis.
14. A method of reducing the effects of dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms, wherein the method comprises contacting the dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms with compound X as defined in any of claims 1 to 7 or an oral care formulation as defined in claim 10 or 11 .
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP23165977 | 2023-03-31 | ||
EP23165977.2 | 2023-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024126876A2 true WO2024126876A2 (en) | 2024-06-20 |
Family
ID=85800372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2024/058509 WO2024126876A2 (en) | 2023-03-31 | 2024-03-28 | Antimicrobial compounds for oral care |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024126876A2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2224973A1 (en) | 2007-11-29 | 2010-09-08 | Inolex Investment Corporation | Preservatives for cosmetic, toiletry and pharmaceutical compositions |
WO2018002100A1 (en) | 2016-06-29 | 2018-01-04 | Clariant International Ltd | Composition for inhibiting micro-organisms |
WO2019152569A2 (en) | 2018-01-30 | 2019-08-08 | Inolex Investment Corporation | Natural 1,2-alkanediols, compositions having natural 1,2-alkanediols and processes for making the same |
-
2024
- 2024-03-28 WO PCT/EP2024/058509 patent/WO2024126876A2/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2224973A1 (en) | 2007-11-29 | 2010-09-08 | Inolex Investment Corporation | Preservatives for cosmetic, toiletry and pharmaceutical compositions |
WO2018002100A1 (en) | 2016-06-29 | 2018-01-04 | Clariant International Ltd | Composition for inhibiting micro-organisms |
WO2019152569A2 (en) | 2018-01-30 | 2019-08-08 | Inolex Investment Corporation | Natural 1,2-alkanediols, compositions having natural 1,2-alkanediols and processes for making the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2787393C (en) | Oral care product for sensitive enamel care | |
US3342687A (en) | Oral preparation | |
RU2722821C2 (en) | Oral care composition | |
US6770268B1 (en) | Non-foaming anti-infective periodontic compositions | |
JPS6038321A (en) | Foamable, fluoride-stable antiplaque dentifirice | |
WO1992008441A1 (en) | Improved anti-plaque compositions comprising a combination of morpholinoamino alcohol and metal salts | |
JP5054914B2 (en) | Oral composition | |
JP2006347987A (en) | Composition for oral cavity and method for enhancing foamability of composition for oral cavity | |
RU2671835C2 (en) | Oral care composition | |
WO2024126876A2 (en) | Antimicrobial compounds for oral care | |
JP2006347986A (en) | Composition for oral cavity | |
US20070292360A1 (en) | Process and composition for oral hygiene | |
JPH021402A (en) | Dentifrice composition | |
JP2002234825A (en) | Composition for oral cavity application | |
JPH0211511A (en) | Composition for oral cavity | |
JP2012097018A (en) | Anti-dental caries agent, antiseptic agent, composition for oral cavities and composition | |
KR102579556B1 (en) | Oral composition | |
KR102574022B1 (en) | oral composition | |
EA030855B1 (en) | Oral care compositions | |
JP2806024B2 (en) | Oral composition | |
JP2002047162A (en) | Composition for oral cavity | |
US8852617B2 (en) | Antimicrobial dental care preparation | |
WO2002050002A1 (en) | Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same | |
KR102642592B1 (en) | Oral composition | |
JP3065947B2 (en) | Oral composition |